Trial Profile
Comparing Methotrexate monotherapy with methotrexate Plus LEflunomide combination ThErapy in Psoriatic Arthritis: A pragmatic randomized placebo-controlled double-blind clinical trial (Vergelijken van methotrexaat monotherapie met methotrexaat en leflunomide combinatie therapie in artritis psoriatica: een pragmatische gerandomiseerde, placebo-gecontroleerde, dubbelblinde klinische trial)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2021
Price :
$35
*
At a glance
- Drugs Leflunomide (Primary) ; Methotrexate
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms COMPLETE-PsA
- 03 Aug 2021 This trial has been completed in Netherlands, according to European Clinical Trials Database record.
- 10 Dec 2018 New trial record